SABCS: Novartis touts Kisqali’s 5-year breast cancer survival, advantage over Pfizer’s Ibrance – FiercePharma
Posted: December 10, 2020 at 4:58 pm
Novartis already knew that adding Kisqali to endocrine therapy can help premenopausal patients with HR-positive, HER2-negative advanced breast cancer live longer. Now, it knows exactly how long.
Kisqali plus endocrine therapy helped pre- and perimenopausal women with HR+/HER2- disease live a median 58.7 months, according to phase 3 data presented at the San Antonio Breast Cancer Symposium's (SABCS') virtual annual meeting. Thats compared with 48 months forendocrine therapy alone, translating to a 24% reduction in the risk of death for the Kisqali regimen.
Deploy Configurable, Fit-for-Purpose ePRO Solutions, Fast.
Clinical Inks enhanced Lunexis ePRO+ module streamlines processes through a flexible, unified platform that allows patients and sites a high degree of optionality.
Jeff Legos, Ph.D., Novartis head of oncology drug development, called Kisqalis new survival showing very impressive given that these patients historically survived for around three years after treatment. Patients in the control arm of the Monaleesa-7 trial appeared to live longer because some went on to receive Kisqali afteran initial survival readout, which showed a 29% reduction in the risk of death.
The Kisqali regimen also extended the time period before patients need follow-up chemotherapy by about 31%. Patients on the Kisqali combo lived a median 50.9 months before their first post-treatment chemo, while the time was 36.8 months for endocrine therapy alone.
The survival benefit was similar in a subgroup of patients who took a nonsteroidal aromatase inhibitor (NSAI) as part of their endocrine therapy. The death risk reduction in those patients was 20%, as the Kisqali group also lived a median 58.7 months, versus 47.7 months for the control arm.
RELATED:ASCO: Novartis' Kisqali posts first-in-class survival win in younger women
Thats the most relevant data for Kisqali in this patient population,given that its only approved by the FDA in combination with an NSAI. The Monaleesa-7 study also tested tamoxifen as an endocrine option, but, in those patients, researchers identified ahigher-than-expected increase in an abnormal heart rhythm called QT prolongation.
Novartis has now reported statistically significant life extension benefits for Kisqali in premenopausal women in the Monaleesa-7 trial and in postmenopausal women in the Monaleesa-3 study.The Monaleesa-2 program testing Kisqali in combination with the endocrine therapy letrozole in previously untreated patients is expected to have overall survival data in the second half of 2021.
The current Monaleesa-7 study was carried out in patients who hadnt been previously treated witha CDK4/6 inhibitor or endocrine therapy, but it did allowprevious treatment with chemotherapy.
Biomarker victory over Ibrance
In a cherry on top of Kisqalis 2020 SABCS data cake, Novartis unveiled a pooled analysis of the three trials showing the CDK4/6 inhibitor reduced the risk of disease progression or death in three of the four main subtypes of breast cancer.
In patients with the more traditional Luminal A and Luminal B subtypes, where Legos said patients have done reasonably OK with solo endocrine therapy, adding Kisqali significantly slashed the risk of disease progression or death by 37% and 48%, respectively, across the three trials.
The best news for Kisqali, though, according to Legos, came fromthe HER2-enriched subtype, which makes up about 15% of the HR+/HER2- breast cancer population. This subgroup traditionally had not done very well on endocrine therapy alone and hence it can be sort of deemed as a poor prognostic factor, Legos explained.
But in this group, the Kisqali-endocrine pairing cut the risk of disease progression or death by 61%.
RELATED:ESMO: Lilly's Verzenio pressures Pfizer with practice-changing win in early breast cancer
The showing in this subtype is important because its the first time a CDK4/6 inhibitor combo topped endocrine therapy alonein these women, Legos said. Three years ago at the SABCS event, a retrospective analysis of the Paloma-2 trial found Pfizers market-leading CDK4/6 inhibitor, Ibrance, didnt benefit the HER2-enriched subtype, he pointed out.
I think this just addsto the growing body of evidence that these mixed results that were seeing in both the metastatic setting, as well as in the adjuvant setting, may suggest that not all of the CDK4/6 inhibitors are equal, Legos said in an interview ahead of the data presentation.
Indeed, Ibrance has repeatedly failed in several HR+/HER2- breast cancer trials. The most famous is the Paloma-3 trial, which showed adding Ibrance to endocrine therapy in metastatic patients didnt significantly beat endocrine therapy at extending patients lives.
RELATED:Pfizer's Ibrance kisses early breast cancer hopes goodbye with 2nd study failure
And, in the postsurgery setting known as adjuvant treatment, Ibrance recently failed to lengthen the time early breast cancer patients could live without invasive disease returning. It didnt deliver a benefit in a wider patient group or in a high-risk subgroup.
Meanwhile, updated data from the phase 3 monarchE trial presented at this years SABCS showed the adjuvant pairing of Eli Lillys rival CDK4/6 inhibitor Verzenio and endocrine therapy reduced the risk of invasive disease after surgery by 28.7% in high-risk patients with an extended follow-up of 19 months.
CDK4 versus CDK6
Novartis has been attributing Kisqalis better efficacyas compared to Ibrancesto its drugs higher inhibition of CDK4 over CDK6. While CDK4 is more widely expressed in breast cancer cells, CDK6 is found more in the bone marrow; plus, CDK4 plays a greater role in cell proliferation and growth, Legos explained. Verzenio also inhibits CDK4 to a higher degree.
Kisqali isnt omnipotent, though. The Novartis drug didnt show a tumor progression improvement in the basal-like subtype. Legos said this represents a small group of patients whose tumors resemble triple-negative breast cancer. These patients constitute an average 3% of participants across the three Monaleesa trials, which Legos said is reflective of the real-world makeup.
Novartis is running a separate trial called Natalee, hoping to show that Kisqali on top of endocrine therapy works as an adjuvant treatment for both intermediate and high-risk patients. Data from that trial areexpected in 2022.
- Life Extension Information, Research and Products [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Life extension - Wikipedia, the free encyclopedia [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Forever Young - Short Documentary (Regenerative Medicine/Life Extension) - Video [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- An argument with a life extension denier - Video [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Life extension deniers part 3: their ignorance and stupidity - Video [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Life extension science, also known as anti-aging medicine, - Video [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- NEWS - Life Extension [Last Updated On: May 22nd, 2015] [Originally Added On: May 22nd, 2015]
- Life Extension Vitamins | Health Supplements | Garcinia ... [Last Updated On: May 22nd, 2015] [Originally Added On: May 22nd, 2015]
- The Life Extension Blog [Last Updated On: July 14th, 2015] [Originally Added On: July 14th, 2015]
- About Life Extension: Anti-Aging, Health Supplements ... [Last Updated On: August 7th, 2015] [Originally Added On: August 7th, 2015]
- Life Extension - Products on Sale, Coupons, Reviews, Free ... [Last Updated On: August 22nd, 2015] [Originally Added On: August 22nd, 2015]
- Life Extension - Reviews - eVitamins.com [Last Updated On: September 2nd, 2015] [Originally Added On: September 2nd, 2015]
- Life Extension Manual - A Guide to Anti-aging, Genomes, and ... [Last Updated On: September 2nd, 2015] [Originally Added On: September 2nd, 2015]
- Vitamins & Supplements | Life Extension Europe [Last Updated On: September 2nd, 2015] [Originally Added On: September 2nd, 2015]
- Life Extension News - Life Enhancement Products [Last Updated On: September 2nd, 2015] [Originally Added On: September 2nd, 2015]
- Life Extension diet & fitness | drugstore.com [Last Updated On: September 2nd, 2015] [Originally Added On: September 2nd, 2015]
- Life Extension: Durk Pearson, Sandy Shaw: 9780446512299 ... [Last Updated On: September 3rd, 2015] [Originally Added On: September 3rd, 2015]
- Life Extension [Last Updated On: September 9th, 2015] [Originally Added On: September 9th, 2015]
- The Las Vegas A4M Conference - Life Extension [Last Updated On: September 22nd, 2015] [Originally Added On: September 22nd, 2015]
- Life Extension Technology and Tissue Regeneration [Last Updated On: October 25th, 2015] [Originally Added On: October 25th, 2015]
- Ann Arbor Life Extension [Last Updated On: October 28th, 2015] [Originally Added On: October 28th, 2015]
- Life Extension Supplements/Products: Antioxidants, Anti ... [Last Updated On: November 4th, 2015] [Originally Added On: November 4th, 2015]
- About Us - Life Extension [Last Updated On: January 27th, 2016] [Originally Added On: January 27th, 2016]
- Most Popular - Life Extension Vitamins [Last Updated On: February 12th, 2016] [Originally Added On: February 12th, 2016]
- Alcor Procedures - Alcor Life Extension Foundation [Last Updated On: February 14th, 2016] [Originally Added On: February 14th, 2016]
- Alcor Life Extension Foundation - Wikipedia, the free ... [Last Updated On: February 19th, 2016] [Originally Added On: February 19th, 2016]
- New... - Life Extension Vitamins [Last Updated On: June 30th, 2016] [Originally Added On: June 30th, 2016]
- Life Extension Mix Tablets, 315 tablets [Last Updated On: July 8th, 2016] [Originally Added On: July 8th, 2016]
- Directory of Innovative Anti-Aging Doctors, Health And ... [Last Updated On: July 18th, 2016] [Originally Added On: July 18th, 2016]
- Hormone / Prostate - Life Extension Vitamins [Last Updated On: July 26th, 2016] [Originally Added On: July 26th, 2016]
- Life Extension - Page 1 - Health Food Emporium [Last Updated On: September 24th, 2016] [Originally Added On: September 24th, 2016]
- Life Extension Super Bio-Curcumin -- 400 mg - 60 ... - Vitacost [Last Updated On: October 18th, 2016] [Originally Added On: October 18th, 2016]
- Life extension - Wikipedia [Last Updated On: October 25th, 2016] [Originally Added On: October 25th, 2016]
- Heart / Circulation - Life Extension Vitamins [Last Updated On: December 2nd, 2016] [Originally Added On: December 2nd, 2016]
- Life Extension - iHerb.com [Last Updated On: January 19th, 2017] [Originally Added On: January 19th, 2017]
- Orbital ATK files suit against DARPA - Inside Defense (subscription) [Last Updated On: February 8th, 2017] [Originally Added On: February 8th, 2017]
- Biotechnology xpert Jamie Metzl addresses realities of genetics revolution, Feb. 9 - Vail Daily News [Last Updated On: February 8th, 2017] [Originally Added On: February 8th, 2017]
- There is No Limit to Human Life Extension - Futurism [Last Updated On: February 8th, 2017] [Originally Added On: February 8th, 2017]
- Human Life Could Be Extended Indefinitely, Study Suggests - EconoTimes [Last Updated On: February 10th, 2017] [Originally Added On: February 10th, 2017]
- DARPA hits snag in GEO satellite service plan - Network World [Last Updated On: February 10th, 2017] [Originally Added On: February 10th, 2017]
- Orbital ATK Sues DARPA Over Satellite-Repairing Robots | Inverse - Inverse [Last Updated On: February 13th, 2017] [Originally Added On: February 13th, 2017]
- Radical Life Extension Is Already Here, But We're Doing it ... [Last Updated On: February 13th, 2017] [Originally Added On: February 13th, 2017]
- Private Space Company Suing US Gov't For Stealing Their Idea ... - Daily Caller [Last Updated On: February 15th, 2017] [Originally Added On: February 15th, 2017]
- SRS's Melter 2 to be replaced | News | northaugustastar.com - The Star [Last Updated On: February 15th, 2017] [Originally Added On: February 15th, 2017]
- Acacia Mining sees 40 percent boost from mine extension | Reuters - Reuters [Last Updated On: February 15th, 2017] [Originally Added On: February 15th, 2017]
- Double-blind, randomized crossover study of intravenous infusion of ... - PR Newswire (press release) [Last Updated On: February 15th, 2017] [Originally Added On: February 15th, 2017]
- Only Human - New Republic [Last Updated On: February 17th, 2017] [Originally Added On: February 17th, 2017]
- Batteroo Boost, The Battery Life Extender Is Now Available Worldwide - PR Newswire (press release) [Last Updated On: February 17th, 2017] [Originally Added On: February 17th, 2017]
- Why Do People Want to Live So Long, Anyway? - TIME [Last Updated On: February 17th, 2017] [Originally Added On: February 17th, 2017]
- Major South African coal extension project on cards South32 - Creamer Media's Mining Weekly [Last Updated On: February 17th, 2017] [Originally Added On: February 17th, 2017]
- Evolution approves Cowal life extension project - Creamer Media's Mining Weekly [Last Updated On: February 17th, 2017] [Originally Added On: February 17th, 2017]
- Should We Die? - The Atlantic [Last Updated On: February 18th, 2017] [Originally Added On: February 18th, 2017]
- When Screening for Disease, Risk is as Important to Consider as ... - University of Virginia [Last Updated On: February 20th, 2017] [Originally Added On: February 20th, 2017]
- A UO lab digs into worms in the quest to lengthen human life - AroundtheO [Last Updated On: February 21st, 2017] [Originally Added On: February 21st, 2017]
- Life Extension Science Live Forever and Don't Pay Taxes - Nanalyze [Last Updated On: February 23rd, 2017] [Originally Added On: February 23rd, 2017]
- Who wants to live forever? Transhumanism's promise of eternal life - Irish Times [Last Updated On: March 18th, 2017] [Originally Added On: March 18th, 2017]
- Editorial March 29 2017 - Illawarra Mercury [Last Updated On: March 28th, 2017] [Originally Added On: March 28th, 2017]
- Life Extension and Insilico Medicine Use Artificial Intelligence to Develop Ageless Cell - WholeFoods Magazine [Last Updated On: March 28th, 2017] [Originally Added On: March 28th, 2017]
- Texas A&M Agri-Life Extension Invites Resident to Partake in - RGVProud [Last Updated On: March 28th, 2017] [Originally Added On: March 28th, 2017]
- Life Extension and Insilico Medicine Use Artificial Intelligence to Develop Ageless - WholeFoods Magazine [Last Updated On: March 31st, 2017] [Originally Added On: March 31st, 2017]
- How does where you live affect your life expectancy? | PBS NewsHour - PBS NewsHour [Last Updated On: May 12th, 2017] [Originally Added On: May 12th, 2017]
- Possible mine-life extension good news for contractors - Otago Daily Times [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- SES and MDA Announce First Satellite Life Extension Agreement - Space Daily [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- GARDENING: Reviving St. Augustine grass - Odessa American [Last Updated On: July 3rd, 2017] [Originally Added On: July 3rd, 2017]
- Does doxycycline treat h pylori ulcers - Shelf life extension program doxycycline - Longboat Key News [Last Updated On: July 6th, 2017] [Originally Added On: July 6th, 2017]
- This Study Could Help Extend the Human Lifespan - Futurism [Last Updated On: July 8th, 2017] [Originally Added On: July 8th, 2017]
- A surgeon aiming to do the first human head transplant says 'Frankenstein' predicted a crucial part of the surgery - South China Morning Post [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]
- Silicon Valley looking to extend life | News, Sports, Jobs - The ... - Tiffin Advertiser Tribune [Last Updated On: July 31st, 2017] [Originally Added On: July 31st, 2017]
- TransCanada still sees producer support for Keystone XL - WorldOil (subscription) [Last Updated On: July 31st, 2017] [Originally Added On: July 31st, 2017]
- US approves $115m sale of F/A-18 Super Hornet upgrades to Switzerland - Airforce Technology [Last Updated On: August 1st, 2017] [Originally Added On: August 1st, 2017]
- BAE Systems sales fire up as tank orders roll in - shropshirestar.com [Last Updated On: August 2nd, 2017] [Originally Added On: August 2nd, 2017]
- New ICBM Cheaper Than Upgraded Minuteman: Boeing On GBSD - Breaking Defense [Last Updated On: August 3rd, 2017] [Originally Added On: August 3rd, 2017]
- BWXT Nuclear Energy Canada Awarded CA$34 Million Contract for Primary Heat Transport Motors - Business Wire (press release) [Last Updated On: August 3rd, 2017] [Originally Added On: August 3rd, 2017]
- BWXT Nuclear Energy Canada in Peterborough lands five-year, $34M deal to make primary heat transport motors for ... - Peterborough Examiner [Last Updated On: August 3rd, 2017] [Originally Added On: August 3rd, 2017]
- FAA Issues Structural Life Extension for Eclipse Jets | Business ... - Aviation International News [Last Updated On: August 3rd, 2017] [Originally Added On: August 3rd, 2017]
- BWXT NEC to provide seven heat transport motors for Bruce Power reactors - Power Technology [Last Updated On: August 4th, 2017] [Originally Added On: August 4th, 2017]
- Johanna and Mario Host Extension Leadership Workshop - KSST (press release) (registration) (blog) [Last Updated On: August 4th, 2017] [Originally Added On: August 4th, 2017]
- Can you take medications past their expiration date? - CBS News [Last Updated On: August 4th, 2017] [Originally Added On: August 4th, 2017]
- Ted Williams will be first baseball player to get 'American Masters' treatment - The Boston Globe [Last Updated On: August 4th, 2017] [Originally Added On: August 4th, 2017]
- Which Giant Tech Company Is Winning the Race to Be Skynet? - Vulture [Last Updated On: August 5th, 2017] [Originally Added On: August 5th, 2017]